These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid. Arisawa M; Then R Biochem J; 1983 Mar; 209(3):609-15. PubMed ID: 6307259 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and beta-lactamase inhibitory activity of 6-fluoropenicillanic acids. Danelon GO; Laborde M; Mascaretti OA; Boggio SB; Roveri OA Bioorg Med Chem; 1993 Dec; 1(6):447-55. PubMed ID: 8087566 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile. Knap AK; Pratt RF Biochem J; 1987 Oct; 247(1):29-33. PubMed ID: 2825657 [TBL] [Abstract][Full Text] [Related]
9. Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899). Labia R; Lelievre V; Peduzzi J Biochim Biophys Acta; 1980 Feb; 611(2):351-7. PubMed ID: 6243991 [TBL] [Abstract][Full Text] [Related]
10. On the chemistry of beta-lactamase inhibition by 6 beta-bromopenicillanic acid. Orlek BS; Sammes PG; Knott-Hunziker V; Waley SG J Chem Soc Perkin 1; 1980; 10():2322-9. PubMed ID: 6253512 [No Abstract] [Full Text] [Related]
11. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chin NX; McElrath MJ; Neu HC Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. Bedini A; Balsamini C; Di Giacomo B; Tontini A; Citterio B; Giorgi L; Di Modugno E; Tarzia G Farmaco; 2002 Aug; 57(8):663-9. PubMed ID: 12361234 [TBL] [Abstract][Full Text] [Related]
13. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated beta-lactamases. Arisawa M; Then RL J Antibiot (Tokyo); 1982 Nov; 35(11):1578-83. PubMed ID: 6298167 [TBL] [Abstract][Full Text] [Related]
14. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism. Christensen H; Martin MT; Waley SG Biochem J; 1990 Mar; 266(3):853-61. PubMed ID: 2158301 [TBL] [Abstract][Full Text] [Related]
15. Interaction of beta-lactamase of Streptomyces cacaoi. II. CP-45,899, izumenolide and cephamycins. Mantoku A; Ogawara H J Antibiot (Tokyo); 1981 Oct; 34(10):1347-50. PubMed ID: 6273376 [TBL] [Abstract][Full Text] [Related]
17. Active sites of beta-lactamases from Bacillus cereus. Hill HA; Sammes PG; Waley SG Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):333-44. PubMed ID: 6109328 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopencillanic acid: mechanism. Cohen SA; Pratt RF Biochemistry; 1980 Aug; 19(17):3996-4003. PubMed ID: 6773559 [TBL] [Abstract][Full Text] [Related]
19. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases. Bonomo RA; Rudin SA; Shlaes DM FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111 [TBL] [Abstract][Full Text] [Related]
20. Beta-lactamase inactivation by mechanism-based reagents. Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]